Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Combination of MK3475 and Metronomic Cyclophosphamide in Patients With
Brief Summary: This is a multicenter study assessing efficacy of the MK 3475 (Pembrolizumab) in combination with metronomic cyclophosphamide in patients with advanced sarcomas.